Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDEA.L Regulatory News (IDEA)

  • There is currently no data for IDEA

VA Contract Update

10 May 2013 07:00

RNS Number : 3944E
Ideagen PLC
10 May 2013
 



 

Ideagen PLC

("Ideagen" or the "Company")

 

VA Contract Update

 

Ideagen PLC (AIM: IDEA), a leading supplier of Compliance based Information Management solutions, announces that the Company has received notification from the US Department of Veterans Affairs (VA) to 'terminate for convenience' year two of the Prism contract expected to complete during November 2013. The cancellation of this contract has no effect on market expectations for the current financial year.

 

As notified in the announcement of 29 November 2012, approximately 70% of the anticipated revenue from year two of the contract of approximately ÂŁ1.05 million was recognised in the financial period ending 30 April 2013. Given the current nature of the US Federal budgets the Company had made ample contingency within its business plan to ensure that in the event of this programme discontinuing following the second year of the contract there would be no impact on the current market expectations for the financial period ending 30 April 2014. The Company therefore remains confident in meeting market expectations for the financial period ending 30 April 2014.

 

The decision to terminate year two of the Prism contract was made for budgetary reasons and the Company remains a trusted and important supplier to the VA and will continue to support the existing deployment of Proquis Enterprise™ at 40 VA hospitals across the USA and to market its products to VA hospitals at a local and regional level.

 

The notice to 'terminate for convenience' the Company's Prism contract is a no fault termination right held by the US Government over all Federal Contracts and, as the Company has complied fully with all commercial and technical contractual obligations, it is entitled to a settlement under Federal Acquisition Regulation (FAR) 52.2124 (i) in respect of the second year of the contract to November 2013. The VA has requested a proposal for settlement from the Company which will be submitted as soon as possible.

 

David Hornsby, Chief Executive of Ideagen, commented, "Whilst we are disappointed that year two of the Prism contract has been terminated, I am pleased to report our budgetary processes were robust. The business continues to trade strongly and the Company remains confident of delivering further revenue and profit growth in the current financial period."

 

Enquiries:

 

 

Ideagen Plc

 

Tel: 01629 761590

David Hornsby, Chief Executive

 

 

Graeme Spenceley, Finance Director

 

 

 

 

 

finnCap (Nominated Adviser and Broker)

 

Tel: 020 7220 0500

Matt Goode/Charlotte Stranner (Corporate Finance)

 

 

Stephen Norcross (Corporate Broking)

 

 

 

 

 

Walbrook PR Ltd

 

Tel: 020 7933 8780

Helen Westaway

 

Helen.westaway@walbrookpr.com

Paul Cornelius

 

Paul.cornelius@walbrookpr.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAPSNEFKDEFF
Date   Source Headline
24th Sep 201810:42 amRNSHolding(s) in Company
17th Sep 20184:42 pmRNSExercise of Options and Total Voting Rights
17th Sep 20184:33 pmRNSHolding(s) in Company
13th Sep 20185:00 pmRNSClosing of conditional Placing to raise £20m
13th Sep 201811:30 amRNSProposed Placing to raise £20 million
5th Sep 20187:00 amRNSAcquisition of InspectionXpert Inc
3rd Sep 20182:36 pmRNSExercise of Options and Total Voting Rights
15th Aug 201812:23 pmRNSHolding(s) in Company
13th Aug 20183:18 pmRNSHolding(s) in Company
13th Aug 20183:05 pmRNSIssue of Shares under Share Incentive Plan and TVR
7th Aug 20181:08 pmRNSHolding(s) in Company
23rd Jul 20183:27 pmRNSIssue of Equity
17th Jul 20187:00 amRNSUnaudited Preliminary Results
18th Jun 20183:38 pmRNSExercise of Options and Total Voting Rights
11th Jun 20185:00 pmRNSIssue of Equity and Total Voting Rights
22nd May 20183:59 pmRNSIssue of Shares under Share Incentive Plan and TVR
15th May 20183:10 pmRNSExercise of Options and Total Voting Rights
9th May 20187:00 amRNSExercise of Options and Total Voting Rights
8th May 20187:00 amRNSPre-Close Trading Update and Board Changes
18th Apr 201810:12 amRNSIssue of Equity
12th Apr 201810:35 amRNSDirector/PDMR Shareholding
11th Apr 20187:00 amRNSDirector/PDMR Shareholding
6th Apr 20187:00 amRNSAcquisition of Medforce Technologies Inc
26th Mar 201812:38 pmRNSHolding(s) in Company
16th Mar 20187:00 amRNSIssue of Shares under Share Incentive Plan and TVR
6th Mar 20183:58 pmRNSExercise of Options and Total Voting Rights
14th Feb 20187:00 amRNSIssue of Equity
23rd Jan 20187:00 amRNSInterim Results
11th Jan 20187:00 amRNSIssue of Equity
13th Dec 201710:18 amRNSDirector Dealing
11th Dec 20172:26 pmRNSIssue of Equity
4th Dec 201712:37 pmRNSExercise of Options and Total Voting Rights
23rd Nov 20177:00 amRNSContract Win
10th Nov 20173:07 pmRNSIssue of Shares under Share Incentive Plan and TVR
7th Nov 20171:26 pmRNSExercise of Options and Total Voting Rights
7th Nov 20177:00 amRNSTrading Update
1st Nov 20175:18 pmRNSPDMR / PCA Dealing
30th Oct 20171:33 pmRNSResult of AGM
25th Oct 20177:00 amRNSExercise of Options and Total Voting Rights
23rd Oct 201710:55 amRNSExercise of Options and Total Voting Rights
16th Oct 20173:30 pmRNSExercise of Options and Total Voting Rights
9th Oct 20174:09 pmRNSIssue of shares under the Share Incentive Plan
6th Oct 20173:13 pmRNSNotice of AGM
27th Sep 20174:28 pmRNSExercise of Options and Total Voting Rights
20th Sep 201710:08 amRNSHolding(s) in Company
4th Sep 20177:00 amRNSBoard Appointment
1st Sep 20173:06 pmRNSIssue of shares under a Share Incentive Plan
11th Aug 20173:00 pmRNSHolding(s) in Company
11th Aug 20178:00 amRNSHolding(s) in Company
10th Aug 20171:36 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.